Human papillomavirus (HPV) is recognised as th most prevalent sexually transmitted infection, causing malignancies. Global HPV vaccination coverage among women aged 9-45 remains at 39.7%, with significant disparities across income levels. Pharmacists play a pivotal role in mitigating its impact through proactive vaccination advocacy, patient education, and the rigorous oversight of immunisation programmes. The aim of this study is to examine pharmacists' impact and effectiveness in managing and promoting HPV vaccination, as well as to emphasize their crucial function in boosting vaccination rates and awareness. A comprehensive literature review was conducted using databases such as PubMed®, Science Direct®, Google Scholar® and Web of Science® to gather relevant information. The review includes studies that examined pharmacists' involvement in HPV vaccination programs and their results. The findings show that pharmacists make a major contribution to increased vaccination rates through educational activities, patient counselling, and active supervision of vaccination programs. Pharmacists often serve as the most accessible healthcare professionals, and their engagement can help to reduce vaccine reluctance, promote adherence to vaccination schedules, and assure effective vaccine delivery. Their engagement increases vaccination rates and awareness, which contributes to the overall decrease of HPV-related diseases. In conclusion, pharmacists play a significant part in vaccination against HPV. Their active engagement in vaccination programs, patient education, and community outreach is critical to increasing vaccination rates and lowering the prevalence of HPV-related diseases. Increased integration of pharmacists into healthcare efforts has the potential to greatly increase the success of HPV vaccination programs and, ultimately, public health outcomes.
Keywords: Human papillomavirus; pharmacist; vaccination; community pharmacy; attitude and behaviour
İnsan papilloma virüs [(Human papillomavirus (HPV)], dünyanın en yaygın cinsel yolla bulaşan enfeksiyonlardan olup birçok maligniteyle ilişkilidir. Kadınlar arasında 9-45 yaş aralığında küresel HPV aşılanma oranı %39,7 seviyesindedir ve gelir düzeyine göre büyük farklılıklar göstermektedir. Eczacılar, hasta eğitimi ve aşılama programlarında sunabileceği hizmetler aracılığıyla HPV'nin etkilerini azaltmada kritik bir rol oynamaktadır. Bu çalışmanın amacı, eczacıların HPV aşılamasını yönetme ve teşvik etme konusundaki etkisini ve etkinliğini incelemek, aşı oranlarını ve farkındalığını artırmadaki kritik rollerini vurgulamaktır. İlgili verileri toplamak için PubMed®, Science Direct®, Google Scholar® ve Web of Science® gibi veri tabanları kullanılarak kapsamlı bir literatür taraması yapılmıştır. Bu derleme, eczacıların HPV aşılaması programlarına katılımını ve sonuçlarını inceleyen çalışmaları içermektedir. Bulgular, eczacıların eğitim faaliyetleri, hasta danışmanlığı ve aşılama programlarının aktif denetimi yoluyla aşılama oranlarının artmasına önemli katkı sağladığını göstermektedir. Eczacılar genellikle en erişilebilir sağlık profesyonelleridir ve katılımları aşı tereddüdünü azaltmaya, aşılama takvimlerine uyumu teşvik etmeye ve etkili aşı teslimatını sağlamaya yardımcı olabilir. Katılımları, aşılama oranlarının ve farkındalığının artmasına katkıda bulunarak HPV ile ilişkili hastalıkların genel olarak azalmasına yardımcı olur. Sonuç olarak, eczacılar HPV'ye karşı aşılamada önemli bir rol oynamaktadır. Aşılama programlarına, hasta eğitimine ve topluma ulaşmaya aktif katılımları, aşılama oranlarının artırılması ve HPV ile ilişkili hastalıkların yaygınlığının azaltılması için kritiktir. Eczacıların sağlık hizmetleri çabalarına daha fazla entegrasyonu, HPV aşı programlarının başarısını ve nihayetinde halk sağlığı sonuçlarını büyük ölçüde artırma potansiyeline sahiptir.
Anahtar Kelimeler: İnsan papilloma virüsü; eczacı; aşılama; toplum eczanesi; tutum ve davranışlar
- Kaliterna V, Barisic Z. Genital human papillomavirus infections. Front Biosci (Landmark Ed). 2018;23(9):1587-611. [Crossref] [PubMed]
- Piña-Sánchez P. Human papillomavirus: challenges and opportunities for the control of cervical cancer. Arch Med Res. 2022;53(8):753-69. [PubMed]
- Bruni L, Diaz M, Castellsagué X, Ferrer E, Bosch FX, de Sanjosé S. Cervical human papillomavirus prevalence in 5 continents: meta-analysis of 1 million women with normal cytological findings. J Infect Dis. 2010;202(12):1789-99. [Crossref] [PubMed]
- Yousefi Z, Aria H, Ghaedrahmati F, Bakhtiari T, Azizi M, Bastan R, et al. An Update on Human Papilloma Virus Vaccines: History, Types, Protection, and Efficacy. Front Immunol. 2022;12:805695. . [Crossref] [PubMed] [PMC]
- Mihretie GN, Liyeh TM, Ayele AD, Belay HG, Yimer TS, Miskr AD, et al. Female adolescents' knowledge and acceptability of human papillomavirus vaccine in Debre Tabor Town, Ethiopia: a cross-sectional study. BMJ Open. 2023;13(3):e061813. [Crossref] [PubMed] [PMC]
- Cipolle RJ, Strand LM, Morley PC. Pharmaceutical Care Practice: The Patient-Centered Approach to Medication Management. 3rd ed. New York, USA; McGraw-Hill Medical: 2012. p. 435-644. [Crossref] [PubMed]
- Poudel A, Lau E, Deldot M, Campbell C, Waite N, Nissen L. Pharmacist role in vaccination: evidence and challenges. Vaccine. 2019;37(40):5939-45. [Crossref]
- Brown V, Tsuyuki RT. The pharmacist's role in prevention of HPV-related cancers. Can Pharm J (Ott). 2021;154(4):228-31. [Crossref] [PubMed] [PMC]
- Dahes S, Damerval M, Bataillard T, Lepiller Q, Nerich V. Knowledge and perceptions of French community pharmacists and pharmacy students about the papillomavirus vaccine. Infect Dis Now. 2024;54(1):104796. [Crossref] [PubMed]
- Dufour L, Carrouel F, Dussart C. Human papillomaviruses in adolescents: knowledge, attitudes, and practices of pharmacists regarding virus and vaccination in France. Viruses. 2023;15(3):778. [Crossref] [PubMed] [PMC]
- Julia B, Farge G, Mourlat B, Mamane C, Bensimon L, Hommel C, et al. Facilitating human papillomavirus vaccination pathways by extending vaccination competencies to community pharmacists: A cross-sectional survey on the acceptability and expectations among healthcare professionals and parents. Explor Res Clin Soc Pharm. 2023;10:100255. [PubMed] [PMC]
- Carney PA, Bumatay S, Kuo GM, Darden PM, Hamilton A, Fagnan LJ, et al. The interface between U.S. primary care clinics and pharmacies for HPV vaccination delivery: A scoping literature review. Prev Med Rep. 2022;28:101893. . [Crossref] [PubMed] [PMC]
- Frietze G, Padilla M, Cordero J, Gosselink K, Moya E. Human Papillomavirus Vaccine Acceptance (HPV-VA) and Vaccine Uptake (HPV-VU): assessing the impact of theory, culture, and trusted sources of information in a Hispanic community. BMC Public Health. 2023;23(1):1781. [Crossref] [PubMed] [PMC]
- Adegboyega A, Obielodan O, Wiggins AT, Dignan M, Williams LB. Beliefs and knowledge related to human papillomavirus (HPV) vaccine among African Americans and African immigrants young adults. Cancer Causes Control. 2023;34(5):479-89. [Crossref] [PubMed] [PMC]
- Maples JM, Zite NB, Oyedeji O, Chamberlin SM, Mastronardi AM, Gregory S, et al. Availability of the HPV Vaccine in regional pharmacies and provider perceptions regarding HPV vaccination in the pharmacy setting. Vaccines (Basel). 2022;10(3):351. [PubMed] [PMC]
- Rancic NK, Miljkovic PM, Deljanin ZM, Marinkov-Zivkovic EM, Stamenkovic BN, Bojanovic MR, et al. Knowledge about HPV infection and the HPV vaccine among parents in Southeastern Serbia. Medicina (Kaunas). 2022;58(12):1697. [Crossref] [PubMed] [PMC]
- Aksoy N, Ozturk N, Ulusoy S, Ömür MF. Knowledge and attitude of students studying at health department towards HPV and HPV vaccination. Vaccine. 2022;40(50):7211-8. [PubMed]
- Teeter BS, Jensen CR, Thomas JL, Martin BC, McElfish PA, Mosley CL, et al. Perceptions of HPV vaccination and pharmacist-physician collaboration models to improve HPV vaccination rates. Explor Res Clin Soc Pharm. 2021;2:100014. [Crossref] [PubMed] [PMC]
- Koskan A, Vizcaino M, Brennhofer SA, Lee CD, Roberto AJ. Human papillomavirus vaccine administration behaviors and influences among Arizona pharmacists and pharmacy interns. Hum Vaccin Immunother. 2021;17(9):3090-5. [Crossref] [PubMed] [PMC]
- Daniel CL, Lawson F, Vickers M, Green C, Wright A, Coyne-Beasley T, et al. Enrolling a rural community pharmacy as a vaccines for children provider to increase HPV vaccination: a feasibility study. BMC Public Health. 2021;21(1):1266. [Crossref] [PubMed] [PMC]
- Ryan G, Daly E, Askelson N, Pieper F, Seegmiller L, Allred T. Exploring opportunities to leverage pharmacists in rural areas to promote administration of human papillomavirus vaccine. Prev Chronic Dis. 2020;17:E23. [PubMed] [PMC]
- Cebollero J, Walton SM, Cavendish L, Quairoli K, Cwiak C, Kottke MJ. Evaluation of human papillomavirus vaccination after pharmacist-led ıntervention: a pilot project in an ambulatory clinic at a large academic Urban Medical Center. Public Health Rep. 2020;135(3):313-21. [Crossref] [PubMed] [PMC]
- Askelson NM, Ryan G, Seegmiller L, Pieper F, Kintigh B, Callaghan D. Implementation challenges and opportunities related to HPV vaccination quality ımprovement in primary care clinics in a Rural State. J Community Health. 2019;44(4):790-5. [Crossref] [PubMed] [PMC]
- Islam JY, Gruber JF, Kepka D, Kunwar M, Smith SB, Rothholz MC, et al. Pharmacist insights into adolescent human papillomavirus vaccination provision in the United States. Hum Vaccin Immunother. 2019;15(7-8):1839-50. [PubMed] [PMC]
- Fernandes R, Potter BK, Little J. Attitudes of undergraduate university women towards HPV vaccination: a cross-sectional study in Ottawa, Canada. BMC Womens Health. 2018;18(1):134. [Crossref] [PubMed] [PMC]
- Tolentino V, Unni E, Montuoro J, Bezzant-Ogborn D, Kepka D. Utah pharmacists' knowledge, attitudes, and barriers regarding human papillomavirus vaccine recommendation. J Am Pharm Assoc (2003). 2018;58(4S):S16-S23. [Crossref] [PubMed]
- Wick JA, Elswick BM. Impact of pharmacist delivered education on early parent awareness and perceptions regarding human papillomavirus (HPV) vaccination in the community pharmacy setting in West Virginia. Innov Pharm. 2018;9(3):1-6. [Crossref] [PubMed] [PMC]
- Shah PD, Marciniak MW, Golden SD, Trogdon JG, Golin CE, Brewer NT. Pharmacies versus doctors' offices for adolescent vaccination. Vaccine. 2018;36(24):3453-9. [PubMed]
- Okuyan B, Bektay MY, Demirci MY, Ay P, Sancar M. Factors associated with Turkish pharmacists? intention to receive COVID-19 vaccine: an observational study. International Journal of Clinical Pharmacy. 2021;44(1):247-55. [Crossref]
- Nazar Z, Naseralallah LM, Stewart D, Paudyal V, Shafei L, Weidmann A. Application of behavioural theories, models, and frameworks in pharmacy practice research based on published evidence: a scoping review. Int J Clin Pharm. 2024;46(3):559-73. [Crossref] [PubMed] [PMC]
.: İşlem Listesi